Medical News

RSS

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Data from two Phase III studies of Merck’s investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting.

3 Mar 2010

Merck announces updated late-stage pipeline following its recent merger with Schering-Plough

Merck & Co., Inc. today announced its updated, newly integrated, late-stage pipeline following its recent merger with Schering-Plough. The new pipeline features a broad and diversified portfolio of investigational medicines and vaccines, including more than 20 candidates in Phase III or under regulatory review, and more than 20 candidates in Phase II of development.

3 Mar 2010

Study: LABA can be effective step-up treatment for children whose asthma is not well controlled

For children whose asthma is not well controlled and on low doses of inhaled corticosteroids, a long-acting beta-agonist (LABA) may be the most effective of three possible step-up treatments. National Jewish clinician-scientists Stanley Szefler, Joseph Spahn, Ronina Covar Gary Larsen and Lynn Taussig, and colleagues in the NIH-funded Childhood Asthma Research and Education Network published their findings March 2, 2010, online in the New England Journal of Medicine.

3 Mar 2010

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.

3 Mar 2010

Total economic impact of foodborne illness across the nation to be a combined $152 billion annually

A new study by a former U.S. Food and Drug Administration (FDA) economist estimates the total economic impact of foodborne illness across the nation to be a combined $152 billion annually.

3 Mar 2010

Blocks to successful implementation of electronic medical records in physician practices introduced

How will the typical American physician practice be transformed years after federal stimulus funds for health information technology are spent? The potential scope of change that electronic health information exchange can bring to modern medical practice is the focus of a presentation that John Blair III, MD, president of Taconic IPA, will bring at the HIMSS Annual Conference and Exhibition March 2 in Atlanta.

3 Mar 2010

RMR can non-invasively, quickly and accurately detect presence of sCAD

Newly published data shows using a Respiratory Modulation Response (RMR) is a novel, non-invasive measure to quickly and accurately detect the presence of significant coronary artery disease (sCAD). Patients in the study with sCAD had a lower RMR compared to patients without, regardless of their risk factors or clinical history of angina, previous myocardial infarction (MI), or angioplasty.

3 Mar 2010

Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, has unveiled its new CELLECTRA®-SP series of hand-held, cordless electroporation devices at the DNA Vaccines 2010 conference being held in New Orleans, LA.

3 Mar 2010

ASPEX to display game-changing PSEM eXpress analyzer at Pittcon 2010

ASPEX Corporation has been advancing the novel Personal Scanning Electron Microscope (PSEM) platform since its first product generation was released in 1992. Since then, it has been "shifting" where SEMs are traditionally installed, "shifting" when SEMs are utilized in industrial processes, and fundamentally "shifting" how SEMs are identified. Come experience the shift at Pittcon 2010, in Orlando, FL from March 1-4.

3 Mar 2010

Stanford University Medical Center buys ASTI's Ecotones Duet Adaptive Sleep Sound Machines

Adaptive Sound Technologies, Inc. (ASTI) announced today that the Stanford University Medical Center has purchased Ecotones Duet Adaptive Sleep Sound Machines. "It is well known that noise in hospitals affects patient comfort and recovery, as well as staff performance. ASTI's adaptive technology can help with these problems," stated Sam Nicolino, President and CEO of ASTI.

3 Mar 2010

Acuo Technologies granted patent covering technology implemented in DSG software suite

Acuo Technologies, the market leading Vendor Neutral Archive supplier, was granted US patent number 7,640,171 by the USPTO which covers technology implemented in its DICOM Services Grid™ software suite.

3 Mar 2010

Toxins in K2: Saint Louis University professor warns parents to lookout for warning signs

In the last month, Anthony Scalzo, M.D., professor of toxicology at Saint Louis University, has seen nearly 30 cases involving teenagers who were experiencing hallucinations, severe agitation, elevated heart rate and blood pressure, vomiting and, in some cases, tremors and seizures. All of these teens had smoked a dangerous, yet legal substance known as K2 or "fake weed."

3 Mar 2010

MSU risk assessment: Reliable method to assess lead-poisoning risk in children

As health departments across the United States seek a better way to determine which children should be tested for lead poisoning, a method created by Michigan State University scientists has proven to be more accurate and cost-effective than current strategies.

3 Mar 2010

Royal Philips Electronics, Microsoft collaborate to improve Philips Healthcare's efficiency and productivity

Royal Philips Electronics today announced collaboration with Microsoft Corp. to build on Philips Healthcare's foundation of healthcare informatics and advanced clinical decision support offerings that drive efficiency and effectiveness at the point of care.

From Philips Healthcare 3 Mar 2010

SCLL signs agreement to provide research and assay services in support of Agennix's talactoferrin program

Stem Cell Innovations announced today that the Company has signed a Master Services Agreement to provide research and assay services in support of Agennix's talactoferrin program. The assay utilizes SCLL's C3A human liver cell line.

3 Mar 2010

China Medical Technologies reports revenues of US$25.2 million for third-quarter fiscal 2009

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced its unaudited financial results for the third fiscal quarter ended December 31, 2009 ("3Q FY2009"). The Company's 2009 fiscal year ends on March 31, 2010 ("FY2009").

3 Mar 2010

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.

3 Mar 2010

Study: Offspring of two parents with schizophrenia more likely to develop same illness

Offspring of two parents with schizophrenia or bipolar disorder appear more likely to develop the same illness or another psychiatric condition than those with only one parent with psychiatric illness, according to a report in the March issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

3 Mar 2010

Enanta Pharmaceuticals nominates EDP-239 lead development candidate from NS5A HCV inhibitor program

Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing.

3 Mar 2010

CFAS supports the provision of publicly funded IVF and ICSI treatment across Canada

The Canadian Fertility and Andrology Society supports fully the provision of publicly funded in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment across Canada. Infertility has been defined by the World Health Organization as a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.

3 Mar 2010

Medical News

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck announces updated late-stage pipeline following its recent merger with Schering-Plough

Study: LABA can be effective step-up treatment for children whose asthma is not well controlled

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

Total economic impact of foodborne illness across the nation to be a combined $152 billion annually

Blocks to successful implementation of electronic medical records in physician practices introduced

RMR can non-invasively, quickly and accurately detect presence of sCAD

Inovio Biomedical introduces new CELLECTRA-SP series of hand-held, cordless electroporation devices

ASPEX to display game-changing PSEM eXpress analyzer at Pittcon 2010

Stanford University Medical Center buys ASTI's Ecotones Duet Adaptive Sleep Sound Machines

Acuo Technologies granted patent covering technology implemented in DSG software suite

Toxins in K2: Saint Louis University professor warns parents to lookout for warning signs

MSU risk assessment: Reliable method to assess lead-poisoning risk in children

Royal Philips Electronics, Microsoft collaborate to improve Philips Healthcare's efficiency and productivity

SCLL signs agreement to provide research and assay services in support of Agennix's talactoferrin program

China Medical Technologies reports revenues of US$25.2 million for third-quarter fiscal 2009

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Study: Offspring of two parents with schizophrenia more likely to develop same illness

Enanta Pharmaceuticals nominates EDP-239 lead development candidate from NS5A HCV inhibitor program

CFAS supports the provision of publicly funded IVF and ICSI treatment across Canada

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Latest News